The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation
The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation
批准号:
9169944
负责人:
Gunnar C. Hansson
金额:
$30.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-22 至 2021-06-30
关键词:
AddressAnabolismAntigensAreaBacteriaBiochemicalBiologicalBiologyBiopsyBody SurfaceCell physiologyCellsColitisColonDefectDendritic CellsDevelopmentDiseaseEpithelialEpithelial CellsExposure toGelGenesGerm-FreeGlutenGoblet CellsHealthHealthcare SystemsHomeostasisImmuneImmune responseImmune systemImmunologyInflammationInternationalIntestinesInvestmentsLamina PropriaLarge IntestineLifeLysineMass Spectrum AnalysisMediatingMeprinMethodsModelingMolecularMuc 2 proteinMucin-2 Staining MethodMucinsMucous body substancePathway interactionsPatientsPeptide HydrolasesPositioning AttributeProcessPropertyProteinsRecombinantsResearchRoleSurfaceSystemTimeTransgenic MiceTransglutaminasesUlcerative ColitisWestern WorldWorkadaptive immunitycell typecostdisulfide bondglycosylationimprovedinterestknockout animalmicrobialmouse modelnoveltransmission processuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
The mucus covering our mucosal surfaces is an intimate part of the innate immune
system and the first line of defense against microbial challenges. This is especially
prominent in the lower parts of the intestine where we have to protect ourselves at
the same time as we live in a symbiotic relation without trigger an overt immune
response. We have shown that colon has a double-layered mucus layer built around
the MUC2 mucin. The inner of these act as a barrier and does not allow bacteria to
penetrate. With an absence of MUC2 or defects in the mucus, bacteria reach the
epithelial cells, penetrate into the crypts, and into the epithelial cells. In experimental
colitis models this inner mucus layer is penetrable to bacteria and in patients with
active colitis. This renewal is to continue studies on how the mucus layers are formed
and built by the use of biochemical methods, especially mass spectrometry, and the
use of various types of gene knock-out animals that are colonized with bacteria or
germ-free. Patient studies on biopsies will follow changes in penetrability processes
over the cyclic changes observed ulcerative colitis. The role of different mucus
proteins on mucus properties will be studied and manipulated by recombinant mucus
proteins and pharmacological agents. The three aims that will be studied are: Aim 1:
To obtain a deeper functional and molecular understanding of the small intestinal
mucus and its main component the MUC2 mucin in relation to mucus detachment,
bacterial selection, and goblet cell uptake of antigens via transglutamination. Aim 2.
To obtain a functional and cell biological understanding of the many different types of
goblet cells in the intestine and their different secretory machinery. Aim 3. To obtain a
functional understanding of how the mucus and its main components protect the
mucosal surfaces of colon and inhibits ulcerative colitis. Expected results are novel
ways to improve the protection of colon and by novel principles of the intestinal
mucosal immunology that could have importance for understanding the disease
ulcerative colitis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The MUC2 Mucus Gel as an Innate Immune Mechanisms that Inhibits Colitis
-
批准号:8499168
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2011
-
负责人:Gunnar C. Hansson
-
依托单位:
The MUC2 Mucus Gel as an Innate Immune Mechanisms that Inhibits Colitis
-
批准号:8179614
-
项目类别:
-
资助金额:$22.68万
-
财政年份:2011
-
负责人:Gunnar C. Hansson
-
依托单位:
The MUC2 Mucus Gel as an Innate Immune Mechanisms that Inhibits Colitis
-
批准号:8912143
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2011
-
负责人:Gunnar C. Hansson
-
依托单位:
The MUC2 Mucus Gel as an Innate Immune Mechanisms that Inhibits Colitis
-
批准号:8304120
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2011
-
负责人:Gunnar C. Hansson
-
依托单位:
海外基金